Patented Medicines (Notice of Compliance) Regulations, SOR/93-133
Section 6.12
Cite as Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, s. 6.12 · current to July 24, 2025 · regulation last amended January 1, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) In an action brought under subsection 6(1) or a counterclaim brought under subsection 6(3), the Federal Court may make any order in respect of costs, including on a solicitor-and-client basis, in accordance with the Federal Courts Rules.
(2) In addition to any other factor that the Federal Court may take into account in making an order in respect of costs, it may consider
(a) the diligence with which the parties have pursued the action;
(b) the extent to which they have reasonably cooperated in expediting the action;
(c) the certification of a patent list that includes a patent that should not have been included under section 4; and
(d) the failure of the first person to keep a patent list up to date in accordance with subsection 4(7).
Read the Patented Medicines (Notice of Compliance) Regulations on the Justice Laws Website ↗
Made under Patent Act, R.S.C. 1985, c. P-4.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.